NUS - NU SKIN ENTERPRISES, INC.


5.77
0.050   0.867%

Share volume: 440,476
Last Updated: 04-25-2025
Wholesale/Wholesale – Drugs & Drug Proprietaries: 0.00%

PREVIOUS CLOSE
CHG
CHG%

$5.72
0.05
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
87%
Profitability 88%
Dept financing 41%
Liquidity 75%
Performance 100%
Company vs Stock growth
vs
Performance
5 Days
4.15%
1 Month
-23.17%
3 Months
-17.45%
6 Months
-6.63%
1 Year
-53.01%
2 Year
-85.39%
Key data
Stock price
$5.77
P/E Ratio 
0.00
DAY RANGE
$5.60 - $5.77
EPS 
-$1.81
52 WEEK RANGE
$5.32 - $14.00
52 WEEK CHANGE
-$53.01
MARKET CAP 
342.509 M
YIELD 
3.48%
SHARES OUTSTANDING 
49.702 M
DIVIDEND
$0.06
EX-DIVIDEND DATE
02-24-2025
NEXT EARNINGS DATE
05-08-2025
BETA 
0.59
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$585,152
AVERAGE 30 VOLUME 
$641,827
Company detail
CEO: Ryan S. Napierski
Region: US
Website: nuskin.com
Employees: 13,400
IPO year: 1996
Issue type: Common Stock
Market: NYSE
Industry: Wholesale/Wholesale – Drugs & Drug Proprietaries
Sector: Wholesale Trade

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, nutritional supplements, weight management and body shaping systems, and other products. Nu Skin sells its products under the Nu Skin, Pharmanex, and ageLOC brands.

Recent news
loading